CLINICAL_TRIALS
trial_result
· 2016-02-12
Clinical Trial Update: Sapropterin on Cognitive Abilities in Young Adults With Phenylketonuria [Phase 2]
Summary
A Phase 2 trial evaluating sapropterin for cognitive abilities in young adults with phenylketonuria was terminated with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: BioMarin Pharmaceutical | Conditions: Phenylketonuria | Phase 2 | Status: TERMINATED | Results posted: 2016-02-12